Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.545 USD | -8.12% | -2.68% | +9.48% |
05-09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.48% | 339M | |
+7.77% | 115B | |
+12.91% | 107B | |
-13.56% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.82% | 14.26B | |
+33.01% | 12.37B | |
-27.87% | 8.28B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Wedbush Lifts Price Target on Mersana Therapeutics to $17 From $16, Keeps Outperform Rating